ConductScience.org, home

Paper12972166

Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.

Kanemitsu H and 2 others. Neurosci Lett, 2003. Cited by 185 papers, by iCite.

Cite this record

ConductScience Library. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Papers, record 12972166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12972166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
PubMed
Journal
Neurosci Lett
PubMed
Year
2003
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
185
iCite
Relative citation ratio, by iCite
4.23
iCite
Revised in PubMed
2019-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kanemitsu HHyoe
2Tomiyama TTakami
3Mori HHiroshi

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amyloid beta-PeptidesMajor topic
BrainMajor topic
NeprilysinMajor topic
Peptide FragmentsMajor topic
Cell Line
Enzyme Inhibitors
Humans
Peptide Hydrolases
RNA, Messenger

Source PubMed

Download CSV of topics

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.

PMIDTitleJournalYearIn PapersSource
42776799Antibody-Based Biologics for CNS Disorders.Antibodies (Basel)2026https://conductscience.org/library/papers/42776799PubMed
42041396Brain Delivery of Antibody-Derived Biologicals for Alzheimer's Disease: An Updated Narrative Review.Antibodies (Basel)2026https://conductscience.org/library/papers/42041396PubMed
41865200
Arsenic Promotes Intracellular Aβ(1-42) Accumulation via Enhanced APP but Reduced NEP Expression, and Indirectly Stimulates Extracellular Aβ Aggregation through AChE Induction in Differentiated SH-SY5Y Cells.
Biol Trace Elem Res2026https://conductscience.org/library/papers/41865200PubMed
40465637Cell-specific protein expression in Alzheimer's disease prefrontal cortex.Alzheimers Dement2025https://conductscience.org/library/papers/40465637PubMed
40387258Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches.J Neurosci Res2025https://conductscience.org/library/papers/40387258PubMed
40233761Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins.Cell Stem Cell2025https://conductscience.org/library/papers/40233761PubMed
39698259Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/39698259PubMed
39309779Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population.Heliyon2024https://conductscience.org/library/papers/39309779PubMed
39013601Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting.Pharmacol Rev2024https://conductscience.org/library/papers/39013601PubMed
38642804Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.J Adv Res2025https://conductscience.org/library/papers/38642804PubMed
38222463Modelling Alzheimer's disease in a dish: dissecting amyloid-β metabolism in human neurons.Neuronal Signal2024https://conductscience.org/library/papers/38222463PubMed
37847125Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.J Cell Mol Med2024https://conductscience.org/library/papers/37847125PubMed
37427403The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition.Front Physiol2023https://conductscience.org/library/papers/37427403PubMed
36471433Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.Alzheimers Res Ther2022https://conductscience.org/library/papers/36471433PubMed
36117918Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies.Front Mol Neurosci2022https://conductscience.org/library/papers/36117918PubMed
35586246Comparative studies for amyloid beta degradation: "Neprilysin vs insulysin", "monomeric vs aggregate", and "whole Aβ40 vs its peptide fragments".Biochem Biophys Rep2022https://conductscience.org/library/papers/35586246PubMed
34743290Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.Clin Transl Oncol2022https://conductscience.org/library/papers/34743290PubMed
34721050Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure.Front Physiol2021https://conductscience.org/library/papers/34721050PubMed
34458738Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.RSC Med Chem2021https://conductscience.org/library/papers/34458738PubMed
34299316Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34299316PubMed

See all 92 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MME4311PubTator's text mininghttps://conductscience.org/library/genes/4311NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12972166

GET https://conductscience.org/api/papers/v1/12972166/cited_by?page=2